Muscle weakness is related to utilization of health care resources in COPD patients

The factors determining utilization of health care resources in patients with chronic obstructive pulmonary disease (COPD) are poorly understood. In order to obtain insight into these factors, we studied the utilization of health care resources in 57 stable COPD patients with a forced expiratory volume in one second (FEV1) of 36 +/- 9% predicted. Patients were divided into two groups: admitted at least twice in the last year (high medical consumption; n = 23) or not admitted in the last year (low medical consumption; n = 34). Other variables related to utilization of health care resources studied were; the number of hospital days; the number of out-patient visits to a pulmonary department in the last year; and the average daily dose (ADD) of corticosteroids taken in the last 6 months. The actual cost of utilization of health care resources, however, was not studied. In addition, pulmonary function, serum electrolytes, blood gas values, 6 min walking distance, respiratory and peripheral muscle force, and appraisal of self-care agency (ASA score) were studied. Pulmonary function, serum electrolytes, blood gas values, ASA score and walking distance were not different between the two groups (e.g. FEV1 36 +/- 8 vs 36 +/- 10% pred). Respiratory muscle forces tended to be lower in the high medical consumption group, this tendency almost reaching statistical significance for maximal expiratory pressure (PE,max) (p = 0.08). Peripheral muscle force, however, was clearly reduced in the high medical consumption group (quadriceps force 63 +/- 20 vs 82 +/- 26% pred; p < 0.05). The number of admissions, the number of hospital days, the number of out-patient visits, and ADD were interrelated and also related to ventilatory and peripheral muscle force (r -0.18 to -0.38). This relationship was statistically significant for PE,max, whilst a similar tendency was present for maximal inspiratory pressure (PI,max). In stepwise multiple regression analysis, only quadriceps force was a significant determinant of utilization of health care services. We conclude that utilization of health care services in patients with chronic obstructive pulmonary disease is related to ventilatory and peripheral muscle force. Whether or not reduced muscle force is simply an expression of disease severity remains to be determined.

This article has been cited by other articles:

				C. Gonzalez, E. Servera, and J. Marin Importance of Noninvasively Measured Respiratory Muscle Overload Among the Causes of Hospital Readmission of COPD Patients Chest, April 1, 2008; 133(4): 941 - 947. [Abstract] [Full Text] [PDF]

				M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF]

				D. D Sin and W D. Reid Is inflammation good, bad or irrelevant for skeletal muscles in COPD? Thorax, February 1, 2008; 63(2): 95 - 96. [Full Text] [PDF]

				C. G. Cote, V. Pinto-Plata, K. Kasprzyk, L. J. Dordelly, and B. R. Celli The 6-Min Walk Distance, Peak Oxygen Uptake, and Mortality in COPD Chest, December 1, 2007; 132(6): 1778 - 1785. [Abstract] [Full Text] [PDF]

				S. J. Carr, R. S. Goldstein, and D. Brooks Acute Exacerbations of COPD in Subjects Completing Pulmonary Rehabilitation Chest, July 1, 2007; 132(1): 127 - 134. [Abstract] [Full Text] [PDF]

				C. A. C. Ottenheijm, L. M. A. Heunks, and P. N. R. Dekhuijzen Diaphragm Muscle Fiber Dysfunction in Chronic Obstructive Pulmonary Disease: Toward a Pathophysiological Concept Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1233 - 1240. [Abstract] [Full Text] [PDF]

				F. Renom, M. Garau, M. Rubi, F. Ramis, A. Galmes, and J. B. Soriano Nosocomial Outbreak of Corynebacterium striatum Infection in Patients with Chronic Obstructive Pulmonary Disease J. Clin. Microbiol., June 1, 2007; 45(6): 2064 - 2067. [Abstract] [Full Text] [PDF]

				M. A. Puhan, G. Busching, H. J. Schunemann, E. vanOort, C. Zaugg, and M. Frey Interval versus Continuous High-Intensity Exercise in Chronic Obstructive Pulmonary Disease: A Randomized Trial Ann Intern Med, December 5, 2006; 145(11): 816 - 825. [Abstract] [Full Text] [PDF]

				C. Esteban, J.M. Quintana, M. Aburto, J. Moraza, and A. Capelastegui A simple score for assessing stable chronic obstructive pulmonary disease QJM, November 1, 2006; 99(11): 751 - 759. [Abstract] [Full Text] [PDF]

				J Garcia-Aymerich, P Lange, M Benet, P Schnohr, and J M Anto Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study Thorax, September 1, 2006; 61(9): 772 - 778. [Abstract] [Full Text] [PDF]

				B. R. Celli Roger S. Mitchell Lecture. Chronic Obstructive Pulmonary Disease Phenotypes and Their Clinical Relevance Proceedings of the ATS, August 1, 2006; 3(6): 461 - 465. [Abstract] [Full Text] [PDF]

				I. Vivodtzev, J.-L. Pepin, G. Vottero, V. Mayer, B. Porsin, P. Levy, and B. Wuyam Improvement in Quadriceps Strength and Dyspnea in Daily Tasks After 1 Month of Electrical Stimulation in Severely Deconditioned and Malnourished COPD Chest, June 1, 2006; 129(6): 1540 - 1548. [Abstract] [Full Text] [PDF]

				P. M. A. Calverley Dynamic Hyperinflation: Is It Worth Measuring? Proceedings of the ATS, May 1, 2006; 3(3): 239 - 244. [Abstract] [Full Text] [PDF]

				B. R. Celli Change in the BODE index reflects disease modification in COPD: lessons from lung volume reduction surgery. Chest, April 1, 2006; 129(4): 835 - 836. [Full Text] [PDF]

				B. R. Celli Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism. Proceedings of the ATS, January 1, 2006; 3(1): 58 - 65. [Abstract] [Full Text] [PDF]

				K.-C. Ong, A. Earnest, and S.-J. Lu A Multidimensional Grading System (BODE Index) as Predictor of Hospitalization for COPD Chest, December 1, 2005; 128(6): 3810 - 3816. [Abstract] [Full Text] [PDF]

				M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 2005; 172(9): 1105 - 1111. [Abstract] [Full Text] [PDF]

				M. A Spruit Enhanced physiotherapy management of acute exacerbations of chronic obstructive pulmonary disease Chronic Respiratory Disease, July 1, 2005; 2(3): 117 - 119. [PDF]

				T. Troosters, R. Casaburi, R. Gosselink, and M. Decramer Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 19 - 38. [Full Text] [PDF]

				M A Puhan, H J Schunemann, M Frey, M Scharplatz, and L M Bachmann How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction Thorax, May 1, 2005; 60(5): 367 - 375. [Abstract] [Full Text] [PDF]

				M.I. Polkey, R. Farre, and A.T. Dinh-Xuan Respiratory monitoring: revisiting classical physiological principles with new tools Eur. Respir. J., November 1, 2004; 24(5): 718 - 719. [Full Text] [PDF]

				W.D-C. Man, J. Moxham, and M.I. Polkey Magnetic stimulation for the measurement of respiratory and skeletal muscle function Eur. Respir. J., November 1, 2004; 24(5): 846 - 860. [Abstract] [Full Text] [PDF]

				S. D. O'Shea, N. F. Taylor, and J. Paratz Peripheral Muscle Strength Training in COPD: A Systematic Review Chest, September 1, 2004; 126(3): 903 - 914. [Abstract] [Full Text] [PDF]

				N. S. Hopkinson, A. H. Nickol, J. Payne, E. Hawe, W. D.-C. Man, J. Moxham, H. Montgomery, and M. I. Polkey Angiotensin Converting Enzyme Genotype and Strength in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 15, 2004; 170(4): 395 - 399. [Abstract] [Full Text] [PDF]

				N. Ambrosino and S. Strambi New strategies to improve exercise tolerance in chronic obstructive pulmonary disease Eur. Respir. J., August 1, 2004; 24(2): 313 - 322. [Abstract] [Full Text] [PDF]

				N. J. M. Cano, C. Pichard, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J.-P. Laaban, J.-C. Melchior, J.-C. Raphael, et al. C-Reactive Protein and Body Mass Index Predict Outcome in End-Stage Respiratory Failure Chest, August 1, 2004; 126(2): 540 - 546. [Abstract] [Full Text] [PDF]

				C. Coronell, M. Orozco-Levi, R. Mendez, A. Ramirez-Sarmiento, J.B. Galdiz, and J. Gea Relevance of assessing quadriceps endurance in patients with COPD Eur. Respir. J., July 1, 2004; 24(1): 129 - 136. [Abstract] [Full Text] [PDF]

				T J Ringbaekl, K Viskuml, and P Lange BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long-term oxygen therapy Chronic Respiratory Disease, April 1, 2004; 1(2): 71 - 78. [Abstract] [PDF]

				E. C Creutzberg Factors associated with prognosis in COPD: influence of body composition and systemic corticosteroid use on morbidity and mortality Chronic Respiratory Disease, April 1, 2004; 1(2): 79 - 81. [PDF]

				B. R. Celli, C. G. Cote, J. M. Marin, C. Casanova, M. Montes de Oca, R. A. Mendez, V. Pinto Plata, and H. J. Cabral The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease N. Engl. J. Med., March 4, 2004; 350(10): 1005 - 1012. [Abstract] [Full Text] [PDF]

				T Troosters Endurance versus strength training in chronic obstructive pulmonary disease 2) Resistance training Chronic Respiratory Disease, January 1, 2004; 1(1): 40 - 41. [PDF]

				M. Orozco-Levi Structure and function of the respiratory muscles in patients with COPD: impairment or adaptation? Eur. Respir. J., November 2, 2003; 22(46_suppl): 41S - 51s. [Abstract] [Full Text] [PDF]

				M I Polkey Peripheral muscle weakness in COPD: where does it come from? Thorax, September 1, 2003; 58(9): 741 - 742. [Full Text] [PDF]

				M A Spruit, R Gosselink, T Troosters, A Kasran, G Gayan-Ramirez, P Bogaerts, R Bouillon, and M Decramer Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I Thorax, September 1, 2003; 58(9): 752 - 756. [Abstract] [Full Text] [PDF]

				W. D.-C. Man, M. G. G. Soliman, J. Gearing, S. G. Radford, G. F. Rafferty, B. J. Gray, M. I. Polkey, and J. Moxham Symptoms and Quadriceps Fatigability after Walking and Cycling in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., September 1, 2003; 168(5): 562 - 567. [Abstract] [Full Text] [PDF]

				W D-C Man, M G G Soliman, D Nikoletou, M L Harris, G F Rafferty, N Mustfa, M I Polkey, and J Moxham Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease Thorax, August 1, 2003; 58(8): 665 - 669. [Abstract] [Full Text] [PDF]

				S.-A. Jansson, F. Andersson, S. Borg, A. Ericsson, E. Jonsson, and B. Lundback Costs of COPD in Sweden According to Disease Severity Chest, December 1, 2002; 122(6): 1994 - 2002. [Abstract] [Full Text] [PDF]

				N.J.M. Cano, H. Roth, I. Court-Fortune, L. Cynober, M. Gerard-Boncompain, A. Cuvelier, J-P. Laaban, J-C. Melchior, C. Pichard, J-C. Raphael, et al. Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation Eur. Respir. J., July 1, 2002; 20(1): 30 - 37. [Abstract] [Full Text] [PDF]

				M.A. Spruit, R. Gosselink, T. Troosters, K. De Paepe, and M. Decramer Resistance versus endurance training in patients with COPD and peripheral muscle weakness Eur. Respir. J., June 1, 2002; 19(6): 1072 - 1078. [Abstract] [Full Text] [PDF]

				M. I. Polkey Muscle Metabolism and Exercise Tolerance in COPD* Chest, May 1, 2002; 121(5_suppl): 131S - 135S. [Abstract] [Full Text] [PDF]

				F. MALTAIS, J. OSTINELLI, J. BOURBEAU, A. B. TONNEL, N. JACQUEMET, J. HADDON, M. ROULEAU, M. BOUKHANA, J. B. MARTINOT, and P. DUROUX Comparison of Nebulized Budesonide and Oral Prednisolone with Placebo in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease . A Randomized Controlled Trial Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 698 - 703. [Abstract] [Full Text] [PDF]

				J. GARCIA-AYMERICH, E. MONSO, R. M. MARRADES, J. ESCARRABILL, M. A. FELEZ, J. SUNYER, J. M. ANTO, and the EFRAM Investigators Risk Factors for Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation . EFRAM STUDY Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1002 - 1007. [Abstract] [Full Text] [PDF]

				K. Foglio, L. Bianchi, and N. Ambrosino Is It Really Useful To Repeat Outpatient Pulmonary Rehabilitation Programs in Patients With Chronic Airway Obstruction? : A 2-Year Controlled Study Chest, June 1, 2001; 119(6): 1696 - 1704. [Abstract] [Full Text] [PDF]

				L. M A Heunks and P N R. Dekhuijzen Respiratory muscle function and free radicals: from cell to COPD Thorax, August 1, 2000; 55(8): 704 - 716. [Full Text]

				H. R Gosker, E. F. Wouters, G. J van der Vusse, and A. M. Schols Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives Am. J. Clinical Nutrition, May 1, 2000; 71(5): 1033 - 1047. [Abstract] [Full Text] [PDF]

				M. P. Engelen, A. M. Schols, J. D Does, and E. F. Wouters Skeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary disease Am. J. Clinical Nutrition, March 1, 2000; 71(3): 733 - 738. [Abstract] [Full Text] [PDF]

				P. Calverley and D. Bellamy Issues at the interface between primary and secondary care in the management of common respiratory disease bullet 5: The challenge of providing better care for patients with chronic obstructive pulmonary disease: the poor relation of airways obstruction? Thorax, January 1, 2000; 55(1): 78 - 82. [Full Text]

				Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease . A Statement of the American Thoracic Society and European Respiratory Society Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): S2 - 40. [Full Text] [PDF]